These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38242995)

  • 21. Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease.
    Liu Y; Uras G; Onuwaje I; Li W; Yao H; Xu S; Li X; Li X; Phillips J; Allen S; Gong Q; Zhang H; Zhu Z; Liu J; Xu J
    Eur J Med Chem; 2022 May; 235():114305. PubMed ID: 35339839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Donepezil-Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer's Disease.
    Queda F; Calò S; Gwizdala K; Magalhães JD; Cardoso SM; Chaves S; Piemontese L; Santos MA
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33809771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel benzofuran-based derivatives as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis, biological evaluation, molecular docking and 3D-QSAR investigation.
    Abd El-Karim SS; Anwar MM; Ahmed NS; Syam YM; Elseginy SA; Aly HF; Younis EA; Khalil WKB; Ahmed KA; Mohammed FF; Rizk M
    Eur J Med Chem; 2023 Nov; 260():115766. PubMed ID: 37678141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and
    David B; Schneider P; Schäfer P; Pietruszka J; Gohlke H
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):491-496. PubMed ID: 33478277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, Synthesis, Molecular Docking, and Molecular Dynamics Simulation Studies of Novel 3-Hydroxypyridine-4-one Derivatives as Potential Acetylcholinesterase Inhibitors.
    Asgarshamsi MH; Fassihi A; Dehkordi MM
    Chem Biodivers; 2023 Jul; 20(7):e202300325. PubMed ID: 37347200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, Synthesis, and Structure-Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer's Disease.
    Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Özkay Y; Kaplancıklı ZA
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32962239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
    Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies.
    Singla S; Piplani P
    Bioorg Med Chem; 2016 Oct; 24(19):4587-4599. PubMed ID: 27519464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
    Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
    Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations.
    Singh M; Kaur M; Singh N; Silakari O
    Bioorg Med Chem; 2017 Dec; 25(24):6273-6285. PubMed ID: 29089261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modeling.
    Samadi A; Estrada M; Pérez C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Marco-Contelles J
    Eur J Med Chem; 2012 Nov; 57():296-301. PubMed ID: 23078965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.
    van Greunen DG; Cordier W; Nell M; van der Westhuyzen C; Steenkamp V; Panayides JL; Riley DL
    Eur J Med Chem; 2017 Feb; 127():671-690. PubMed ID: 27823887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
    Chaves S; Resta S; Rinaldo F; Costa M; Josselin R; Gwizdala K; Piemontese L; Capriati V; Pereira-Santos AR; Cardoso SM; Santos MA
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32098407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Benzylated (Pyrrolidin-2-one)/(Imidazolidin-2-one) Derivatives as Potential Anti-Alzheimer's Agents: Synthesis and Pharmacological Investigations.
    Gupta M; Ojha M; Yadav D; Pant S; Yadav R
    ACS Chem Neurosci; 2020 Sep; 11(18):2849-2860. PubMed ID: 32816447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and evaluation of hydrazones as dual inhibitors of ryanodine receptors and acetylcholinesterases for Alzheimer's disease.
    Yang F; Zhao J; Chen G; Han H; Hu S; Wang N; Wang J; Chen Y; Zhou Z; Dai B; Hou Y; Liu Y
    Bioorg Chem; 2023 Apr; 133():106432. PubMed ID: 36841050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.
    Jiang X; Liu C; Zou M; Xie H; Lin T; Lyu W; Xu J; Li Y; Feng F; Sun H; Liu W
    Eur J Med Chem; 2021 Nov; 223():113663. PubMed ID: 34198150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of dual cation-π inhibitors of acetylcholinesterase: design, synthesis and biological evaluation.
    Damuka N; Kammari K; Potshangbam AM; Rathore RS; Kondapi AK; Vindal V
    Pharmacol Rep; 2020 Jun; 72(3):705-718. PubMed ID: 32200493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.